Clinical Trial Update: Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

This entry updates a Phase 2 chemotherapy trial for newly diagnosed acute myeloid leukemia, chronic myeloid leukemia, and myelodysplastic syndromes, indicating …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED